Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Ridgway,
Gu Zhang,
Yan Wu,
Scott Stawicki,
Wei-Ching Liang,
Yvan Chanthery,
Joe Kowalski,
Ryan J. Watts,
Christopher Callahan,
Ian Kasman,
Mallika Singh,
May Chien,
Christine Tan,
Jo-Anne S. Hongo,
Fred de Sauvage,
Greg Plowman and
Minhong Yan ()
Additional contact information
John Ridgway: Tumor Biology & Angiogenesis
Gu Zhang: Tumor Biology & Angiogenesis
Yan Wu: Antibody Engineering
Scott Stawicki: Antibody Engineering
Wei-Ching Liang: Antibody Engineering
Yvan Chanthery: Tumor Biology & Angiogenesis
Joe Kowalski: Tumor Biology & Angiogenesis
Ryan J. Watts: Tumor Biology & Angiogenesis
Christopher Callahan: Pathology
Ian Kasman: Pathology
Mallika Singh: Molecular Biology, Genentech, Inc.
May Chien: Molecular Biology, Genentech, Inc.
Christine Tan: Antibody Engineering
Jo-Anne S. Hongo: Antibody Engineering
Fred de Sauvage: Molecular Biology, Genentech, Inc.
Greg Plowman: Tumor Biology & Angiogenesis
Minhong Yan: Tumor Biology & Angiogenesis
Nature, 2006, vol. 444, issue 7122, 1083-1087
Abstract:
Blood line VEGF, or vascular endothelial growth factor, is the best-characterized inducer of tumour angiogenesis, and the blockade of VEGF has become an important tool in cancer therapy. But VEGF blockade is not effective against all tumours, so the search for alternative approaches continues. Two groups this week report that one such alternative could be blockade of Dll4, Delta-like ligand 4. This transmembrane molecule is part of the Notch signalling pathway. It was known to be essential for normal development of blood vessels in the embryo: the new work shows that it is also required for tumour angiogenesis. It may be a viable — and potentially well tolerated — alternative in patients with solid tumours that are resistant to anti-VEGF therapy.
Date: 2006
References: Add references at CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.nature.com/articles/nature05313 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:444:y:2006:i:7122:d:10.1038_nature05313
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/nature05313
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().